TWST - Company ID 0001581280
The table below shows Twist Bioscience Corp's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $122.67M | $148.59M | $201.37M | $210.44M | $221.40M | $239.14M |
| Short-term investments | $49.00M | $49.36M | $49.42M | $46.71M | $49.42M | $50.28M |
| Receivables | $64.15M | $50.06M | $49.85M | $49.95M | $39.31M | $31.99M |
| Inventory | $33.52M | $32.92M | $25.94M | $20.86M | $23.52M | $28.48M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $323.44M |
| $303.88M |
| $339.78M |
| $338.44M |
| $345.31M |
| $361.83M |
| Property, plant & equipment | $111.23M | $105.12M | $95.35M | $97.14M | $100.67M | $106.34M |
| Goodwill | $82.19M | $82.19M | $82.19M | $85.81M | $85.81M | $85.81M |
| Total assets | $676.21M | $638.09M | $643.61M | $595.62M | $608.58M | $638.12M |
| Accounts payable | $14.68M | $12.49M | $11.98M | $8.06M | $7.50M | $6.63M |
| Total current liabilities | $119.98M | $80.44M | $87.07M | $74.98M | $69.65M | $73.76M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $221.12M | $181.99M | $165.41M | $155.51M | $152.64M | $146.98M |
| Retained earnings | -$1.39B | -$1.35B | -$1.29B | -$1.31B | -$1.27B | -$1.21B |
| Total equity | $455.09M | $456.10M | $478.20M | $440.11M | $455.94M | $491.14M |